Kristin Yarema Poseida Therapeutics, Inc. (PSTX) insider trading activity

PSTX Quotes by TradingView

Kristin Yarema is President and CEO of Poseida Therapeutics, Inc.. Currently has a direct ownership of 0 shares of PSTX, which is worth approximately $0. The most recent transaction as insider was on Jan 08, 2025, when has been sold 615,836 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Kristin Yarema Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
615,836 Reduced 100.0%
0 Common Stock
Jan 02 2024
BUY
Grant, award, or other acquisition
-
250,000 Added 29.18%
606,836 Common Stock
Apr 11 2023
BUY
Grant, award, or other acquisition
-
356,836 Added 50.0%
356,836 Common Stock

Also insider at

ATRA
Atara Biotherapeutics, Inc. Healthcare
Chief Commercial Officer
KY

Kristin Yarema

President and CEO
South San Francisco, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PSTX